Latest Breaking News On - Marketing authorization application - Page 8 : vimarsana.com

Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights

June 16, 2024 PDUFA date for imetelstat NDA for the treatment of transfusion-dependent anemia in adult patients with lower-risk MDS .

Johna scarlettGeron corporation nasdaqClinical developmentExchange commissionEuropean medicines agencyDrug administrationGeron corporationNew drug applicationChief executiveFast trackNobel prize winningPrescription drug user fee actMarketing authorization applicationPrivate securities litigation reform actMonths ended march

ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand

ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New zealandRichard lowenthalDanielle dowellJustin chakmaCommittee for medicinal products human useExchange commissionPharmaceuticals incEuropean unionEuropean medicines agencyMarketing authorization applicationMedicinal productsHuman useExecutive directorCommercial operationsPrivate securities litigation reform actAnnual report

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Chapel hillUnited statesMarcus maurerKatja arnoldChristopher sayedLaurie doyleRegina lutzJan medinaHarvard medical schoolUniversity of mainzAsthma european networksMc servicesEuropean medicines agencyInstitute of allergologyExchange commissionNational institutes of health

ARS Pharma Submits Response For Neffy MAA To EMA s CHMP, Signs License Deal With CSL Seqirus

ARS Pharmaceuticals (SPRY), Tuesday announced the submission of Day 180 response for Neffy's Marketing Authorization Application to the Committee for Medicinal Products for Human Use of the European Medicines Agency, expecting to receive the opinion on the drug in the second quarter of 2024.

New zealandCommittee for medicinal products human useMarketing authorization applicationMedicinal productsHuman useEuropean medicines agencyArs pharma deal with csl seqirusEffy drug for allergic reactionsRs pharma allergic drug

MorphoSys AG Reports First Quarter 2024 Financial Results

MorphoSys AG Reports First Quarter 2024 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMonjuvi minjuviDennis riedlEamonn nolanJulia neugebauerThomas biegiJean paul kressXencor incGroup revenuesExchange commissionGerman federal financial supervisory authority the bafinDevelopment rd expensesDrug administrationConstellation pharmaceuticals incAdditional groupShare of loss associates